In 2023, Germany led in analgesic medicine sales per capita at $40.2 PPP, followed by Belgium at $35.2 PPP and Spain at $32 PPP. Noteworthy growth was observed in Germany (6.17%) and Finland (6.12%), showcasing a robust demand. Conversely, Denmark (-2.83%) and Hungary (-3.77%) registered declines, indicating possible market saturation or effective substitution therapies. Notably, Costa Rica exhibited the highest year-on-year growth at 8.45%, suggesting emerging market opportunities.
Future trends to watch include the proliferation of over-the-counter (OTC) analgesics, increasing aging populations, and shifts towards non-opioid pain management, which could drive stable growth in countries showing current upticks in demand. Additionally, innovations in drug delivery systems and personalized medicine may shape market dynamics significantly.
Top countries in Analgesic Medicine Sales by Country
| # | 10 Countries | US Dollars PPP Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 40.2 | 2023 | +6.63% | +6.17% | View data |
| 2 | 2 Belgium | 35.2 | 2023 | +2.03% | +5.06% | View data |
| 3 | 3 Spain | 32 | 2023 | +5.61% | +4.73% | View data |
| 4 | 4 Czech Republic | 26.9 | 2023 | +9.35% | 0% | View data |
| 5 | 5 Denmark | 22.7 | 2023 | -0.87% | -2.83% | View data |
| 6 | 6 Canada | 20.7 | 2023 | -5.48% | -1.48% | View data |
| 7 | 7 Finland | 18.3 | 2023 | +1.1% | +6.12% | View data |
| 8 | 8 Italy | 10.6 | 2023 | +4.95% | +2.87% | View data |
| 9 | 9 Chile | 10.3 | 2023 | +6.19% | -1.84% | View data |
| 10 | 10 Hungary | 3.3 | 2023 | +6.45% | -3.77% | View data |
